(Q43796849)

26 November 2017

title

Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients (English)

1 reference

26 November 2017

1 reference

3

Ljungman P

1 reference

26 November 2017

Sandström M

1

1 reference

26 November 2017

Karlsson MO

2

1 reference

26 November 2017

Hassan Z

4

1 reference

26 November 2017

Jonsson EN

5

1 reference

26 November 2017

Nilsson C

6

1 reference

26 November 2017

Ringden O

7

1 reference

26 November 2017

Oberg G

8

1 reference

26 November 2017

Bekassy A

9

1 reference

26 November 2017

Hassan M

10

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Bone Marrow Transplantation

26 November 2017

published in

1 reference

26 November 2017

volume

28

1 reference

26 November 2017

issue

7

1 reference

26 November 2017

page(s)

657-664

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703229

26 November 2017

exact match

0 references

cites work

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

The importance of modeling interoccasion variability in population pharmacokinetic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

7 January 2021

Pharmacokinetic and metabolic studies of busulfan in rat plasma and brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

7 January 2021

Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

7 January 2021

Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

7 January 2021

An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

7 January 2021

Pharmacokinetics of high-dose busulfan in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

7 January 2021

Determination of busulfan in human plasma by gas chromatography with electron-capture detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

7 January 2021

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

7 January 2021

Pharmacokinetic and metabolic studies of high-dose busulphan in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

7 January 2021

Relationship of plasma pharmacokinetics of high-dose oral busulfan to the outcome of allogeneic bone marrow transplantation in children with thalassemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703229

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703229

1 reference

Dimensions Publication ID

26 November 2017

1040106054

0 references

1 reference